Sun Qiulian, Tang Ling, Cheng Jiefei, Ren Dongqing, Guo Xinchun
Department of Radiology, The Fifth People's Hospital of Suzhou, The Affiliated Infectious Diseases Hospital of Soochow University, No.10, Guangqian Road, Suzhou, 215100, Jiangsu Province, China.
Department of Radiology, Taizhou Fourth People's Hospital, No.99, Gulou Road, Tai Zhou City, 225300, Jiangsu Province, China.
Eur J Med Res. 2025 Aug 13;30(1):747. doi: 10.1186/s40001-025-03039-8.
To conduct a comparative assessment of the safety and efficacy of the port repositioning technique and the port re-implantation technique in treating periport skin infections associated with totally implantable venous access ports (TIVAPs).
A retrospective analysis was performed on 35 patients who presented with periport skin infections at Jiangyin People's Hospital between June 2016 and August 2022. Among them, 15 patients in Group A underwent port repositioning surgery, while 20 patients in Group B received port re-implantation surgery. Clinical data of all patients were meticulously collected, including postoperative wound healing status and the functionality of the repositioned or re-implanted TIVAPs.
In Group A, the median age was 58 years (IQR 46-63 years); in Group B, the median age was 60.5 years (IQR 54.3-70 years). The median BMI of Group A patients was 22.2 kg/m (IQR 20.4-23.5 kg/m); the median BMI of Group B patients was 21.5 kg/m (IQR 20.5-23.1 kg/m). Technical success was achieved in all patients (100%), and all ports were functional postoperatively. In Group A, the median indwelling time of the repositioned TIVAPs was 7 months (IQR 4-11 months); in Group B, the median indwelling time of the newly re-implanted TIVAPs was 5 months (IQR 3-8 months); there was no statistically significant difference between the two groups (P > 0.05).
Compared with the port re-implantation technique, the port repositioning technique for periport skin infections is a minimally invasive and cost-effective approach. Nevertheless, further investigations with a larger number of cases are required to comprehensively validate its safety and reliability.
对端口重新定位技术和端口重新植入技术在治疗与完全植入式静脉通路端口（TIVAP）相关的端口周围皮肤感染中的安全性和有效性进行比较评估。
对2016年6月至2022年8月期间在江阴市人民医院出现端口周围皮肤感染的35例患者进行回顾性分析。其中，A组15例患者接受了端口重新定位手术，而B组20例患者接受了端口重新植入手术。精心收集了所有患者的临床资料，包括术后伤口愈合情况以及重新定位或重新植入的TIVAP的功能。
A组患者的中位年龄为58岁（四分位间距46 - 63岁）；B组患者的中位年龄为60.5岁（四分位间距54.3 - 70岁）。A组患者的中位BMI为22.2kg/m（四分位间距20.4 - 23.5kg/m）；B组患者的中位BMI为21.5kg/m（四分位间距20.5 - 23.1kg/m）。所有患者均取得技术成功（100%），且所有端口术后均功能良好。A组中重新定位的TIVAP的中位留置时间为7个月（四分位间距4 - 11个月）；B组中新重新植入的TIVAP的中位留置时间为5个月（四分位间距3 - 8个月）；两组之间差异无统计学意义（P＞0.05）。
与端口重新植入技术相比，用于端口周围皮肤感染的端口重新定位技术是一种微创且具有成本效益的方法。然而，需要更多病例的进一步研究来全面验证其安全性和可靠性。
